DK3107554T3 - Antistof til påvirkning af kønsforholdet og metoder til anvendelse deraf - Google Patents
Antistof til påvirkning af kønsforholdet og metoder til anvendelse deraf Download PDFInfo
- Publication number
- DK3107554T3 DK3107554T3 DK15752006.5T DK15752006T DK3107554T3 DK 3107554 T3 DK3107554 T3 DK 3107554T3 DK 15752006 T DK15752006 T DK 15752006T DK 3107554 T3 DK3107554 T3 DK 3107554T3
- Authority
- DK
- Denmark
- Prior art keywords
- gender
- antibodies
- affecting
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461942020P | 2014-02-19 | 2014-02-19 | |
| US201462065797P | 2014-10-20 | 2014-10-20 | |
| PCT/US2015/016589 WO2015127055A1 (en) | 2014-02-19 | 2015-02-19 | Antibody for skewing sex ratio and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3107554T3 true DK3107554T3 (da) | 2020-10-19 |
Family
ID=53797916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15752006.5T DK3107554T3 (da) | 2014-02-19 | 2015-02-19 | Antistof til påvirkning af kønsforholdet og metoder til anvendelse deraf |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20150233920A1 (da) |
| EP (2) | EP3107554B1 (da) |
| JP (1) | JP6967852B2 (da) |
| AU (2) | AU2015219008B2 (da) |
| BR (1) | BR112016018826A8 (da) |
| CA (1) | CA2938767A1 (da) |
| DK (1) | DK3107554T3 (da) |
| MX (2) | MX2016010623A (da) |
| PL (1) | PL3107554T3 (da) |
| WO (1) | WO2015127055A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7005498B2 (ja) | 2016-01-04 | 2022-01-21 | ユニヴァーシティ オブ テネシー リサーチ ファウンデーション | 精液特性の改善方法 |
| CN112889088A (zh) * | 2018-10-31 | 2021-06-01 | 合同会社予幸集团中央研究所 | 程序、学习模型、信息处理装置、信息处理方法、信息显示方法和学习模型的制造方法 |
| US11760793B2 (en) | 2020-12-18 | 2023-09-19 | University Of Tennessee Research Foundation | Antibody for skewing sex ratio and methods of use thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5346990A (en) * | 1987-04-08 | 1994-09-13 | Cytogam, Inc. | Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex |
| CA1341328C (en) * | 1989-06-07 | 2001-12-25 | Glenn F. Spaulding | Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| AU2133401A (en) * | 1999-12-07 | 2001-06-18 | University Of Guelph | Sex-chromosome-specific proteins, species specific and sperm specific proteins and methods for their identification and isolation |
| US7713687B2 (en) * | 2000-11-29 | 2010-05-11 | Xy, Inc. | System to separate frozen-thawed spermatozoa into x-chromosome bearing and y-chromosome bearing populations |
| WO2005042721A2 (en) * | 2003-10-31 | 2005-05-12 | Abs Global, Inc. | A method for altering the gender ratio of offspring in mammals by manipulation of spermatozoa |
| CA2568512A1 (en) * | 2006-12-04 | 2008-06-04 | Ab Biotech Inc. | Gender selection with the use of antibodies |
| BRPI0814343A2 (pt) * | 2007-07-23 | 2017-10-03 | Androgenix Ltd | Materiais e métodos para a seleção da sexagem do esperma |
| CA2793945A1 (en) * | 2009-04-01 | 2011-10-21 | Biocern, Inc. | Sperm cell separation methods and compositions containing sperm cell targeting ligands for use therein |
| GB0910826D0 (en) * | 2009-06-23 | 2009-08-05 | Ovasort Ltd | Identification of sex-linked proteins |
-
2015
- 2015-02-19 WO PCT/US2015/016589 patent/WO2015127055A1/en active Application Filing
- 2015-02-19 EP EP15752006.5A patent/EP3107554B1/en active Active
- 2015-02-19 US US14/626,401 patent/US20150233920A1/en not_active Abandoned
- 2015-02-19 EP EP20176716.7A patent/EP3782630A1/en active Pending
- 2015-02-19 MX MX2016010623A patent/MX2016010623A/es unknown
- 2015-02-19 JP JP2016552532A patent/JP6967852B2/ja active Active
- 2015-02-19 AU AU2015219008A patent/AU2015219008B2/en active Active
- 2015-02-19 DK DK15752006.5T patent/DK3107554T3/da active
- 2015-02-19 PL PL15752006T patent/PL3107554T3/pl unknown
- 2015-02-19 BR BR112016018826A patent/BR112016018826A8/pt not_active Application Discontinuation
- 2015-02-19 CA CA2938767A patent/CA2938767A1/en active Pending
-
2016
- 2016-08-16 MX MX2022008298A patent/MX2022008298A/es unknown
-
2020
- 2020-12-24 AU AU2020294293A patent/AU2020294293A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NZ722893A (en) | 2023-08-25 |
| EP3107554A1 (en) | 2016-12-28 |
| EP3107554A4 (en) | 2017-09-27 |
| EP3782630A1 (en) | 2021-02-24 |
| BR112016018826A8 (pt) | 2020-06-30 |
| JP6967852B2 (ja) | 2021-11-17 |
| WO2015127055A1 (en) | 2015-08-27 |
| PL3107554T3 (pl) | 2020-12-28 |
| US20150233920A1 (en) | 2015-08-20 |
| AU2015219008A1 (en) | 2016-08-25 |
| MX2022008298A (es) | 2022-08-08 |
| CA2938767A1 (en) | 2015-08-27 |
| EP3107554B1 (en) | 2020-07-22 |
| AU2020294293A1 (en) | 2021-01-28 |
| AU2015219008B2 (en) | 2020-10-01 |
| JP2017507137A (ja) | 2017-03-16 |
| MX2016010623A (es) | 2017-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3227336T3 (da) | Anti-CD79b-antistoffer og fremgangsmåder til anvendelse | |
| DK3280441T3 (da) | Anti-sortilin-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3356404T3 (da) | Anti-pd1-antistoffer og fremgangsmåder til anvendelse | |
| DK3148579T3 (da) | Anti-gitr antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3215532T3 (da) | Anti-TIM3-antistoffer og fremgangsmåder til anvendelse | |
| DK3295951T3 (da) | Anti-pvrig-antistoffer og fremgangsmåder for anvendelse | |
| DK3230319T3 (da) | Anti-PD-1-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3303394T3 (da) | Anti-ctla-4-antistoffer og fremgangsmåder til anvendelse deraf | |
| KR20180084817A (ko) | 항-siglec-9 항체 및 이의 이용 방법 | |
| DK3229838T3 (da) | Anti-C10orf54-antistoffer og anvendelser deraf | |
| DK3292149T3 (da) | Aktiverbare anti-cd71-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3350220T3 (da) | Anti-pro/latente-myostatin-antistoffer og anvendelser deraf | |
| DK3149042T3 (da) | PD-L1-antistoffer og anvendelser deraf | |
| DK3126388T3 (da) | Anti-EGFRvIII-antistoffer og anvendelser deraf | |
| DK3126394T3 (da) | Anti-OX40-antistoffer og fremgangsmåder til anvendelse | |
| DK3292150T3 (da) | Aktiverbare anti-cd166-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3307322T3 (da) | Humaniserede anti-cd40-antistoffer og anvendelser deraf | |
| DK3191135T3 (da) | Anti-HER2-antistoffer og immunokonjugater | |
| DK3215147T3 (da) | Neurodæmpende norketamin-forbindelser og fremgangsmåder | |
| DK3309174T3 (da) | ANTI-PD-L1-antistoffer og diagnostiske anvendelser deraf | |
| DK3316909T3 (da) | Anti-ntb-a-antistoffer og relaterede sammensætninger og fremgangsmåder | |
| DK3102673T3 (da) | Fremgangsmåder og sammensætninger til behandling af beta-talassæmi | |
| DK3116911T3 (da) | Anti-mcam-antistoffer og tilhørende fremgangsmåder til anvendelse | |
| DK3250610T3 (da) | Fcrn-antistoffer og fremgangsmåder til anvendelse heraf | |
| DK3113797T3 (da) | Antistoffer, anvendelser og fremgangsmåder |